Every ingredient in CardioVive analyzed individually for dosage, research backing, cardiovascular relevance, and what we know (and don't know) about the formula.
CardioVive's ingredient list is divided into two distinct groups. The first group contains four vitamins and minerals with individually listed dosages. The second group is a 528 mg proprietary botanical blend containing 13 plant-based ingredients, where only the total blend weight is disclosed, not the individual dose of each ingredient. Understanding this structure is essential for evaluating the formula's potential strengths and limitations.
For context on how these ingredients work together as a system, see our guide to how CardioVive works across its three mechanism layers.
Vitamin C is essential for collagen synthesis, which maintains the structural integrity of blood vessel walls. It functions as a potent water-soluble antioxidant, protecting the vascular endothelium from oxidative damage caused by free radicals. Research consistently links adequate Vitamin C intake with reduced cardiovascular risk. At 90 mg, CardioVive provides the full daily recommended value, covering your baseline needs without reaching the megadose levels (500 to 2000 mg) sometimes used in therapeutic contexts.
Vitamin D regulates calcium metabolism, supports heart muscle contractile function, and influences blood pressure through the renin-angiotensin system. The cholecalciferol form (D3) is the most bioavailable supplemental version. Research from the NIH Office of Dietary Supplements associates Vitamin D deficiency with increased cardiovascular risk. At 125% of the daily value, this is a meaningful but moderate dose appropriate for maintaining adequate status.
Magnesium acts as a natural calcium antagonist, promoting vascular smooth muscle relaxation and supporting healthy heart rhythm. It is one of the most well-established minerals for blood pressure regulation. However, the dose in CardioVive at just 20 mg (5% of the daily value) is genuinely low. Clinical blood pressure studies typically use 300 to 500 mg per day. While magnesium oxide is a common supplemental form, it has lower bioavailability than forms like magnesium glycinate or citrate. CardioVive's magnesium contribution should be viewed as supplementary, not standalone therapeutic support.
Chromium picolinate enhances insulin receptor sensitivity, helping cells respond more efficiently to insulin and supporting stable blood glucose levels. The connection between blood sugar instability and cardiovascular damage (through glycation of blood vessel walls) is well-documented. At 286% of the daily value, this is a meaningful dose that reflects the formula's emphasis on the metabolic dimension of heart health. Chromium picolinate is the most bioavailable form of supplemental chromium.
Contains curcumin, one of the most extensively studied natural anti-inflammatory compounds. Research demonstrates effects on NF-kB pathway inhibition, COX-2 enzyme modulation, and endothelial function improvement. Curcumin is typically studied at 500 to 1500 mg of standardized extract per day. Within a 528 mg total blend, turmeric cannot reach these standalone study doses. However, curcumin's effects may be amplified by interaction with other anti-inflammatory compounds in the formula.
Rich in flavanols that stimulate nitric oxide production, causing blood vessels to relax and widen. Clinical research consistently links cocoa flavanol intake with improved blood flow and modest blood pressure reduction. The American Heart Association has referenced research supporting flavanol-rich diets for cardiovascular benefit.
One of the most researched natural metabolic compounds. Activates AMPK, the body's metabolic master switch, supporting healthy blood sugar, LDL cholesterol, and triglyceride levels. Multiple clinical trials demonstrate berberine's effects at doses of 500 to 1500 mg per day. This is the most commonly discussed ingredient in the proprietary blend transparency debate, as its typical studied dose exceeds the entire blend's weight.
Traditional Ayurvedic herb known as the "sugar destroyer." Research supports its role in reducing sugar absorption in the gut and improving insulin function. Gymnemic acids are the active compounds. Contributes to the formula's six-ingredient blood sugar support cluster.
Contains polyphenols with documented effects on insulin sensitivity and fasting blood glucose. Several meta-analyses of clinical trials support cinnamon's role in supporting healthy blood sugar levels. Also provides antioxidant protection to cardiovascular tissues.
Contains oleuropein, a potent antioxidant with specific cardiovascular applications. Research demonstrates blood pressure-lowering effects and improved LDL oxidation resistance. Olive leaf extract is a key component of Mediterranean diet research, which is consistently associated with cardiovascular longevity.
An adaptogenic root that supports the body's ability to handle physical and psychological stress without excessive cortisol elevation. Chronic stress is a major driver of cardiovascular strain. Eleuthero also supports adrenal function, which influences blood pressure regulation. Users often report improved stress resilience as one of the earliest noticeable benefits.
Traditionally used as a mild diuretic and circulatory tonic. May help the body manage fluid balance, reducing the volume-related component of blood pressure. Also provides antioxidant compounds that contribute to the formula's overall protective action.
Among the most rigorously studied botanicals for vascular health. Supports nitric oxide production, improves microcirculation, and demonstrates anti-inflammatory properties in multiple human trials. Pine bark extract (Pycnogenol-type compounds) has particularly strong evidence for improving blood flow in the lower extremities.
Used in traditional medicine across Asia and the Caribbean for blood sugar management. Contains charantin and polypeptide-p, compounds that mimic insulin-like activity and support glucose uptake by cells. Contributes to the formula's metabolic support dimension.
Contains corosolic acid, which facilitates glucose transport into cells and has demonstrated blood sugar-lowering effects in clinical studies. Works synergistically with chromium and berberine to create a multi-compound approach to glucose regulation.
Contains ruscogenins that specifically support venous tone and circulatory efficiency. Recognized in European herbal pharmacopeias for its effects on chronic venous insufficiency. Particularly valued for reducing leg heaviness and swelling associated with poor venous return.
Used in Ayurvedic medicine for centuries for cholesterol support. Contains guggulsterones that influence thyroid activity and lipid metabolism. Modern research supports modest effects on LDL cholesterol and triglycerides, contributing to the formula's cholesterol-balancing dimension.
The supplement facts label also lists other ingredients used in capsule construction and manufacturing: hypromellose (vegetable capsule shell), microcrystalline cellulose (filler), magnesium stearate (flow agent), stearic acid (lubricant), and silicon dioxide (anti-caking agent). These are standard, widely used excipients found in the vast majority of dietary supplements and are generally recognized as safe.
The most significant criticism of CardioVive's ingredient profile is the proprietary blend format. With 13 botanicals sharing a total weight of 528 mg, simple arithmetic tells us that the average ingredient receives approximately 40 mg, far below the clinical study doses for most of these compounds. Even allowing for an uneven distribution (where some ingredients receive more than others), it is mathematically impossible for any single ingredient to reach the doses used in most published clinical trials.
Does this mean the formula cannot work? Not necessarily. There are legitimate reasons why multi-ingredient formulas at sub-clinical individual doses may still produce meaningful effects: synergistic interactions where multiple compounds amplify each other's effects, additive effects where many small contributions sum to a meaningful total, and the nanoparticle technology which may improve bioavailability beyond what standard delivery achieves.
However, consumers deserve the ability to evaluate a formula against published research, and the proprietary blend format prevents this. Our recommendation is that the manufacturer move toward full dose disclosure in future iterations. For more on what the formula does and does not deliver, see our analysis of whether CardioVive actually works and our detailed benefits breakdown.